000			01931 a2200565 4500
005			20250516221846.0
264		0	_c20150330
008			201503s 0 0 eng d
022			_a1536-4844
024	7		_a10.1097/MIB.0000000000000115 _2doi
040			_aNLM _beng _cNLM
100	1		_aArmuzzi, Alessandro
245	0	0	_aLong-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. _h[electronic resource]
260			_bInflammatory bowel diseases _cAug 2014
300			_a1368-74 p. _bdigital
500			_aPublication Type: Journal Article; Observational Study
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAzathioprine _xtherapeutic use
650	0	4	_aColitis, Ulcerative _xdrug therapy
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGastrointestinal Agents _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInfliximab
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aRemission Induction
650	0	4	_aRetrospective Studies
650	0	4	_aSteroids _xadministration & dosage
650	0	4	_aSurvival Rate
700	1		_aPugliese, Daniela
700	1		_aDanese, Silvio
700	1		_aRizzo, Gianluca
700	1		_aFelice, Carla
700	1		_aMarzo, Manuela
700	1		_aAndrisani, Gianluca
700	1		_aFiorino, Gionata
700	1		_aNardone, Olga Maria
700	1		_aDe Vitis, Italo
700	1		_aPapa, Alfredo
700	1		_aRapaccini, Gian Lodovico
700	1		_aGuidi, Luisa
773	0		_tInflammatory bowel diseases _gvol. 20 _gno. 8 _gp. 1368-74
856	4	0	_uhttps://doi.org/10.1097/MIB.0000000000000115 _zAvailable from publisher's website
999			_c23971131 _d23971131